Serum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

Gene expression of connective tissue growth factor in relation to nephropathy in patients with type 2 diabetes

Urinary connective tissue growth factor level in relation to nephropathy and retinopathy in patients with type 2 diabetes

Association between Growth Differentiation Factor 15 and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

Correlation of Fibroblast Growth Factor 21 (FGF-21) with Fetal and Maternal Complications in Patients with Gestational Diabetes Mellitus

The Relation Between Fibroblast Growth Factor 21 and Insulin Resistance in hyperlipidemia Patients

Connective tissue growth factor among elderly patients with type 2 diabetes: Correlation with diabetic nephropathy

FETUIN A AS AN EARLY MARKER OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS